EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
20/08/2024
Voltar para busca
Dado oficial do USPTO
VERITAS IN SILICO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VERITAS IN SILICO
ST13
US500000079295799Classe
1, 5, 40, 41, 42
Pedido
79295799
Registro
6848721
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
20/08/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 41, 42
Data de depósito
05/06/2020
Data de registro
20/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/09/2022
Última transação
20/08/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
OSGOOD, KRYSTINA
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Veritas In Silico Inc.
Representantes
Sean K. Owens Wood Herron & Evans LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalsnamely chemicals for use in medical industry and medical science; small molecule compounds as chemicals for use in medical science and medical industry; nucleic acids for laboratory use excluding the use in industrial chemistryother than for medical or veterinary purposes; nucleic acid chemical reagents excluding the use in research or development in industrial chemistryother than for medical or veterinary purposes; reagents and assays for use in scientificmedical or drug discovery research; reagents for chemical analysesexcluding the use in research or development in industrial chemistryother than for medical or veterinary purposes; reagents for nucleic acid isolation and purification for medical and drug discovery research purposes; reagents for nucleic acid synthesis and analysis for medical and drug discovery research purposes; diagnostic preparations and assay samples for medical and drug discovery researchclinical researchlaboratory useother than for medical or veterinary purposes; proteins in raw material form and enzymes for scientific and medical research purposes; cells for research or scientific purposes; nucleic acidDNA deoxyribonucleic acids for laboratory use; nucleic acidRNA ribonucleic acids for laboratory use; antibodiesantibody reagents for research useother than for medical or veterinary purposes; artificial sweeteners; raw materialsunprocessed plastics in all forms; none of the foregoing for use in research or development in industrial chemistry
Classe 5
Pharmaceutical preparations targeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; reagent paper for medical purposes; pharmaceutical preparations targeting messenger RNA or other types of RNAother than for agricultural purposes for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; drugs for medical purposestargeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; biological preparations for medical purposestargeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; nucleic acid sequences for medical and veterinary purposes; cells for medical purposes; blood for medical purposes; diagnostic and therapeutic antibodies for medical purposes; vaccines; enzyme inhibitorsonly for medical or veterinary purposes; medical assay preparations for therapeutic or diagnostic purposes; medical diagnostic reagents; reagents for medical purposes; reagents for extracting nucleic acidsonly for medical or veterinary diagnostic purposes; pharmaceutical preparations containing nucleic acidstargeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; reagents for detectionidentificationanalysis and quantification of nucleic acids for pharmaceutical and diagnostic medical purposes; enzymes for medical purposes; lacteal flour for babies; dietary supplements for humans; dietetic foods in liquid form adapted for medical purposes; dietetic foods adapted for medical purposes; beveragesdietetic foods in the form of liquid for babies; food for babies; dietary supplements for animals
Classe 40
Custom manufacturing of pharmaceuticals for others; custom synthesis in the nature of custom manufacturing of nucleic acids for others for use in medicines and pharmaceutical preparations; custom extractionpurificationsynthesiscustom manufacturing of pharmaceuticals for others by utilizing genome editing or gene editing technology; custom synthesis in the nature of custom manufacturing of chemical compounds for others for use in medicines and pharmaceutical preparations; custom synthesis in the nature of custom manufacturing of chemical compounds for others; providing material treatment information; printing
Classe 41
Educational and instruction servicesorganizing events for educational and teaching purposes relating to artscraftssports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arrangingconducting and organization of seminars; arrangingconducting and organization of symposiumslecture meetingsworkshops and study groups; arrangingconducting and organization of educational seminarssymposiumslecture meetingsworkshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazinesnewslettersjournals and books in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicinechemicals and engineering; reference libraries of literature and documentary records; book rental; providing online musicsound recordingsvideos featuring information and instruction on nucleic acidspharmaceuticalsdrug discovery and developmentmedicinechemicals and engineeringimages and character text informationnon-downloadable; educational services in the nature of providing exhibits of academic materials in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicinechemicals and engineering; art exhibitions; publication of books; movie theatre presentationsmovie showing and movie film production and distribution; production of videotape film in the field of educationcultureentertainment or sportsnot for movies or television programs and not for advertising or publicity
Classe 42
Custom design of chemical reagents and biological assays for use in medicines and engineering design servicesnot for advertising; development of pharmaceutical preparations and medicines; computer software designcomputer programmingmaintenance of computer software for use in RNA targeted drug discovery and development; designingprogramming and maintenance of computer software having artificial intelligence functionality for use in RNA targeted drug discovery and development; computer software designcomputer programmingmaintenance of computer software for use in scientific and technical analysis of data from artificial intelligence for use in RNA targeted drug discovery and development; computer software designcomputer programmingmaintenance of computer software for use in analysistestingscreeningdesigningdevelopment or research on nucleic acidspharmaceuticals or chemicals for use in medicines for use in RNA targeted drug discovery and development; computer software designcomputer programmingmaintenance of computer software for use in drug discovery screening; computer software designcomputer programmingmaintenance of computer software for use in genome research or treatmentspharmaceutical preparations for RNA targeted drug discovery and development; technological advice relating to computersautomobiles and other industrial machines requiring highly specialized knowledgeskills and experiences for proper operationcomputer technology consultancy and industrial machine part design consulting for use in RNA targeted drug discovery and development; scientific researchtesting and analysis in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicineschemicals and engineering for use in RNA targeted drug discovery and development; quality control assessment services for use in RNA targeted drug discovery and development for others; testinginspection or research of pharmaceuticals for use in RNA targeted drug discovery and development; providing information and consultancy on testinginspection or research of pharmaceuticalschemicals for use in medicinesreagents for use in medicines for use in RNA targeted drug discovery and development; scientific or laboratory testinginspection or research of nucleic acidschemicals and pharmaceuticals for drug development and medical research purposesproviding scientific information and research consultancy relating thereto for use in RNA targeted drug discovery and development; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto for use in RNA targeted drug discovery and development; genomic experimentsanalysesresearchassaystestsinspectiondetection or verificationscientific genomic analysesscientific genomic researchcustom design and development of biochemical genomic assaysgenome amplification and functional and structural analysis of genomes for use in RNA targeted drug discovery and development; scientific research consultancyadvice and providing scientific research information in the field of genomic experimentsanalysesresearchassaystestsinspectiondetection or verification for use in RNA targeted drug discovery and development; scientific and technological servicestestinganalysis surveyingresearch or data analysis in the field of biomedicinegenome biologypharmacogenomicsdiagnosticsclinical trials and bioengineering for use in RNA targeted drug discovery and development; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceuticals for use in RNA targeted drug discovery and development for others; rental of computers; providing computer programs on data networksproviding temporary use of non-downloadable computer software for enablingsupporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for enablingsupporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; providing online non-downloadable computer software for analyzing science and technology data based on artificial intelligence (AI) technology for use in RNA targeted drug discovery and development; providing online non-downloadable computer software for analyzingtestingscreeningdesigningdeveloping and researching of nucleic acidspharmaceuticals and chemicals for use in RNA targeted drug discovery and development; providing online non-downloadable computer software for drug discovery screening; providing online non-downloadable computer software for conducting and accessing genome research and treatmentspharmaceutical preparations for use in RNA targeted drug discovery and development
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/08/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
23/01/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
25/11/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/01/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/12/2022
FIMP
FINAL DISPOSITION PROCESSED
22/12/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
20/09/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
14/08/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
25/05/2022
APET
ASSIGNED TO PETITION STAFF
24/05/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/05/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
28/04/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/04/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2022
PUBO
PUBLISHED FOR OPPOSITION
05/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/03/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
23/03/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/03/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
16/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/03/2022
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
02/03/2022
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
08/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/06/2021
GNRT
NON-FINAL ACTION E-MAILED
24/06/2021
CNRT
NON-FINAL ACTION WRITTEN
24/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2021
RFNT
REFUSAL PROCESSED BY IB
29/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/11/2020
RFRR
REFUSAL PROCESSED BY MPU
12/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
23/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/10/2020
CNRT
NON-FINAL ACTION WRITTEN
21/10/2020
DOCK
ASSIGNED TO EXAMINER
19/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VERITAS IN SILICO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.